0
Laboratory and Animal Investigations |

Relationship of BAL and Lung Tissue CD4+ and CD8+ T Lymphocytes, and Their Ratio in Idiopathic Pulmonary Fibrosis*

Spyros A. Papiris, MD, FCCP; Androniki Kollintza, MSc; Panagiota Kitsanta, MD; George Kapotsis, MD; Marilena Karatza, PhD; Josef Milic-Emili, CM, MD, FRSC; Charis Roussos, MD, MSc, PhD, MRS; Zoe Daniil, MD
Author and Funding Information

*From the Departments of Critical Care and Pulmonary Services (Drs. Papiris, Kapotsis, Roussos, and Daniil, and Mr. Kollintza), Pathology (Dr. Kitsanta), and Hematology (Dr. Karatza), National and Kapodistrian University of Athens, “Evangelismos” Hospital, Athens, Greece; and Meakins-Cristie Laboratories (Dr. Milic-Emili), McGill University, Montreal, QC, Canada.

Correspondence to: Spyros A. Papiris, MD, FCCP, Associate Professor, Department of Critical Care and Pulmonary Services, 45-47 Ipsilantou St, “Evangelismos” Hospital, GR 10675, Athens, Greece; e-mail: papiris@otenet.gr



Chest. 2005;128(4):2971-2977. doi:10.1378/chest.128.4.2971
Text Size: A A A
Published online

Background: Surgical biopsy specimens have shown that T lymphocytes (TLs) infiltrate lung parenchyma in patients with idiopathic pulmonary fibrosis (IPF) and might play a pathogenetic role. BAL, a far less invasive technique, has also been used for the investigation of IPF pathogenesis. However, controversy exists whether the BAL fluid cellular profile reflects the cellular composition of the lung parenchyma.

Study objective: To compare infiltrating TLs subpopulations (CD4+, CD8+, and CD4+/CD8+ ratio) in lung tissue and BAL fluid.

Patients and methods: Immunohistochemistry was performed according to the streptavidin-biotin method on the surgical biopsy specimens of 12 untreated patients with IPF. The number of CD3+, CD4+, and CD8+ TLs was determined by observer-interactive computerized image analysis (SAMBA microscopic image processor; Meylan, France). In BAL fluid, the same TLs subpopulations were evaluated by flow cytometry.

Results: In lung tissue, CD3+ TLs accounted for a mean (± SEM) of 28.8 ± 7% of total cells, CD4+ TLs accounted for 14.5 ± 4% of total cells (50.1 ± 4% of CD3+ TLs), and CD8+ TLs accounted for 13.8 ± 4% of total cells (47.4 ± 4% of CD3+ TLs). In BAL fluid, lymphocytes accounted for 9.8 ± 2.5% of total cells, CD4+ TLs accounted for 51.8 ± 4% of CD3+ TLs, and CD8+ TLs accounted for 42.2 ± 4% of CD3+ TLs. Tissue CD4+ and CD8+ TLs (expressed as a percentage of CD3+ TLs) correlated significantly with the number of CD4+ and CD8+ TLs in BAL fluid (r = 0.846 and p = 0.001 vs r = 0.692 and p = 0.013, respectively). A significant positive correlation was also found between the mean CD4+/CD8+ ratio found in tissue and BAL fluid (1.05 ± 0.21 and 1.5 ± 0.27, respectively; r = 0.832; p = 0.01).

Conclusion: The results suggest that in patients with IPF, the TL subpopulations in BAL fluid reflect the pattern of lymphocytic infiltration in pulmonary parenchyma.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543